(NP (NP (JJ CD14-mediated) (NN signal) (NN pathway)) (PP (IN of) (NP (NN Porphyromonas) (NN gingivalis) (NN lipopolysaccharide))) (PP (IN in) (NP (JJ human) (JJ gingival) (NNS fibroblasts))) (. .))
(S (NP-SBJ (NP (NN Lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-))) (VP (VBZ induces) (NP (NP (NN expression)) (PP (IN of) (NP (JJ inflammatory) (NNS cytokines))) (PP (IN in) (NP (NNS (macrophages monocytes))))) (PP (IN via) (NP (NP (NN CD14)) (, ,) (NP (NP (CD one)) (PP (IN of) (NP (DT the) (NN LPS) (NNS receptors)))) (, ,) (SBAR (WHNP-74 (WDT which)) (S (NP-SBJ-75 (-NONE- *T*-74)) (VP (VBZ is) (VP (VBN expressed) (NP (-NONE- *-75)) (ADVP (RB predominantly)) (PP (IN in) (NP (DT these) (NNS cells)))))))))) (. .))
(S (NP-SBJ (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated) (SBAR (IN that) (S (NP-SBJ-76 (NP (NN Porphyromonas) (NN gingivalis) (NN LPS)) (PRN (-LRB- -LRB-) (NP (NN P-LPS)) (-RRB- -RRB-))) (ADVP (RB also)) (VP (VBZ is) (ADJP-PRD (JJ able) (S (NP-SBJ (-NONE- *-76)) (VP (TO to) (VP (VB induce) (NP (JJ inflammatory) (NNS cytokines)) (PP (IN in) (NP (JJ human) (JJ gingival) (NNS fibroblasts))))))))))))) (. .))
(S (ADVP (RB Therefore)) (, ,) (NP-SBJ (NP (PRP it)) (S (-NONE- *EXP*-77))) (VP (VBZ is) (ADJP-PRD (JJ important)) (S-77 (NP-SBJ (-NONE- *)) (VP-COOD (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP-SBJ-78 (NN CD14)) (VP (VBZ is) (VP (VBN expressed) (NP (-NONE- *-78)) (PP (IN in) (NP (JJ gingival) (NNS fibroblasts))))))))) (CC and) (VP (TO to) (VP (VB define) (NP (NP (DT the) (JJ P-LPS-mediated) (JJ signal-transducing) (NN mechanism)) (PP (IN in) (NP (DT the) (NNS cells))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP-SBJ (PRP we)) (VP (VBD observed) (ADVP (RB unexpectedly)) (PP (IN by) (NP (UCP-COOD (ADJP (JJ immunohistochemical)) (, ,) (NP (NP (JJ Western) (NN blotting)) (PRN (-LRB- -LRB-) (NP (NN immunoblotting)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN Northern) (-LRB- -LRB-) (NN RNA) (-RRB- -RRB-) (NN blotting))) (NNS assays))) (SBAR (IN that) (S (NP-SBJ-79 (NN CD14)) (VP (VBZ is) (VP (VBN expressed) (NP (-NONE- *-79)) (PP (IN at) (NP (JJ high) (NN density))) (PP (IN in) (NP (JJ human) (JJ gingival) (NNS fibroblasts)))))))) (. .))
(S (NP-SBJ-80 (NP (JJ P-LPS-induced) (NN expression)) (PP (IN of) (NP (DT the) (NP (NP (NN monocyte) (NN chemoattractant) (NN protein) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN MCP-1)) (-RRB- -RRB-))) (NN gene))) (PP (IN in) (NP (DT the) (NNS cells)))) (VP-COOD (VP (VBD was) (VP (VBN inhibited) (NP (-NONE- *-80)) (ADVP (RB markedly)) (PP (IN by) (NP-LGS (NP (NN treatment)) (PP (IN with) (NP (JJ anti-human) (NN CD14) (NN antibody))))))) (CC and) (VP (VBD was) (VP (ADVP (RB completely)) (VBN inhibited) (NP (-NONE- *-80)) (PP (IN by) (NP-LGS (NP (NN herbimycin) (NN A)) (, ,) (NP (NP (DT a) (JJ potent) (NN inhibitor)) (PP (IN of) (NP (NN tyrosine) (NN kinase))))))))) (. .))
(S (NP-SBJ (DT The) (NN inhibitor)) (ADVP (RB also)) (VP (ADVP (RB dramatically)) (VBD inhibited) (NP (NP-COOD (NP (NP (NN monocyte) (JJ chemotactic) (NN activity)) (PP (IN of) (NP (-NONE- *RNR*-104)))) (CC and) (NP (NP (NN MCP-1) (NN production)) (PP (IN by) (NP (-NONE- *RNR*-104))))) (NP-104 (DT the) (NNS cells)))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP-SBJ-82 (NP (JJ P-LPS-induced) (NN expression)) (PP (IN of) (NP (DT the) (JJ MCP-1) (NN gene))) (PP (IN in) (NP (DT the) (NNS cells)))) (ADVP (RB also)) (VP (VBD was) (VP (VBN blocked) (NP (-NONE- *-82)) (PP (IN by) (NP-LGS (NP (NNS inhibitors)) (PP (IN of) (NP (NP (CD two) (NN transcription) (NNS factors)) (, ,) (NP (ADVP (FW i.e.)) (, ,) (NP-COOD (NP (NP (NN curcumin)) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN AP-1)))) (, ,)) (CC and) (NP (NP (NN pyrolidine) (NN dithiocarbamate)) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN NF-kappaB))))))))))))) (. .))
(S (NP-SBJ (DT Both) (NNS inhibitors)) (VP (VBD inhibited) (NP (NN monocyte) (JJ chemotactic) (NN activity)) (PP (IN in) (NP (NP (DT the) (NN culture) (JJ supernatant)) (PP (IN of) (NP (JJ P-LPS-treated) (NNS cells)))))) (. .))
(S (NP-SBJ (NN Gel) (NN shift) (NN mobility) (NN assay)) (VP (VBD showed) (NP (NP (NN stimulation)) (PP (IN of) (NP (DT the) (NP-COOD (NP (NN AP-1)) (CC and) (NP (NN NF-kappaB))) (NNS contents))) (PP (IN in) (NP (JJ P-LPS-treated) (NNS cells))))) (. .))
(S (NP-SBJ (DT This) (NN study)) (VP (VBZ is) (NP-PRD (NP (DT the) (JJ first)) (SBAR (WHNP-83 (-NONE- 0)) (S (NP-SBJ (-NONE- *T*-83)) (VP-COOD (VP (TO to) (VP (VB demonstrate) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN CD14))) (PP (IN in) (NP (JJ human) (JJ gingival) (NNS fibroblasts)))))) (CC and) (VP (TO to) (VP (VB show) (SBAR (IN that) (S (NP-SBJ-84 (NP (DT the) (JJ signal-transducing) (NN pathway)) (PP (IN of) (NP (NN P-LPS))) (PP (IN in) (NP (DT the) (NNS cells)))) (VP (VBZ is) (VP (VBN mediated) (NP (-NONE- *-84)) (PP (IN by) (NP-LGS (NN CD14)))))))))))))) (. .))
